Transforming growth factor-β1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

Cancer

Volumn 91, Issue 5, 2001, Pages 964-971

  Hasegawa, Yukihiro ^a   Takanashi, Shingo ^a   Kanehira, Yutaka ^a   Tsushima, Takao ^a   Imai, Tadashi ^b   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Angiogonesis; Lung carcinoma; Microvessel count; Prognosis; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION FUNCTION; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035281783     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O     Document Type: Article

References (52)

1. The transforming growth factor-β family
2. Transforming growth factor-β: Possible roles in carcinogenesis
3. Inhibition and promotion of differentiated-like phenotype of a human lung carcinoma in athymic mice by natural and recombinant forms of transforming growth factor-β
4. Transforming growth factors type-β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines
5. Transforming growth factor-β1 (TGF-β1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF-β1 antisense expression plasmid
6. Expression of multiple growth factors in a human lung cancer cell line
7. Transforming growth factor-β1 as a biomarker for prostate cancer
8. Expression of transforming growth factor-β1 in human bladder cancer
9. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential
10. The role of fibroblasts in tumor behavior
11. Immunohistochemical staining for transforming growth factor-β1 associates with disease progression in human breast cancer
12. Transforming growth factor-β1 in ductal carcinoma in situ and invasive carcinomas of the breast
13. Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma
14. p21waf1/cip1 and transforming growth factor-β1 protein expression correlate with survival in non-small cell lung cancer
15. The tumor-promoting effect of wounding: A possible role for TGF-β induced stromal alterations
16. What is the evidence that tumors are angiogenesis dependent?
17. Angiogenesis in cancer, vascular, rheumatoid and other disease
18. Relation of neovascularisation to metastasis of non-small-cell lung cancer
19. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
20. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
21. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
22. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
23. Angiogenesis research is on fast forward
24. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
25. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis
26. Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor
27. Excessive production of transforming growth factor-β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: Validity of neutralizing antibodies to block tumor growth
28. The World Health Organization histological typing of lung tumours. Second edition
29. Revisions in the International System for Staging Lung Cancer
30. Spatial and temporal control of gene therapy using ionizing radiation
31. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
32. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer
33. Nonparametric estimation from incomplete observations
34. Regression model and life table
35. Transforming growth factor β1 induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane
36. Anti-transforming growth factor (TGF)- β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of rumor cell/host TGF-β interactions in human breast cancer progression
37. Macrophages and angiogenesis
38. Colon carcinoma cells switch their response to transforming growth factor-β1 with tumor progression
39. Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small cell human lung carcinoma lines
40. Expression of transforming growth factor β ligand and receptor messenger RNAs in lung cancer cell lines
41. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines
42. Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: Results of an immunohistochemical study
43. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
44. Altered expression of transforming growth factor-β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix
45. Transforming growth factor-β1, interleukin-8 and interleukin-1, in non-small-cell lung tumors
46. Enhanced expression of transforming growth factor-β isoforms in pancreatic cancer correlates with decreased survival
47. Basic fibroblast growth factor and transforming growth factor-β1: Synergistic mediators of angiogenesis in vitro
48. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
49. Prognostic value of angiogenesis in operable non-small cell lung cancer
50. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
51. The expression of transforming growth factor-β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma
52. Role of transforming growth factor-β1 in invasion and metastasis in gastric carcinoma